Gene profiling reveals hydrogen sulphide recruits death signaling via the N-methyl-D-aspartate receptor identifying commonalities with excitotoxicity

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1308-1322

  Chen, Minghui Jessica ^a   Peng, Zhao Feng ^b,c   Manikandan, Jayapal ^b   Melendez, Alirio J ^b   Tan, Gek San ^d   Chung, Ching Ming ^d   Li, Qiu Tian ^e   Tan, Theresa M ^b   Deng, Lih Wen ^b   Whiteman, Matthew ^f   Beart, Philip M ^g   Moore, Phillip K ^h   Cheung, Nam Sang ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINA UNIVERSITY OF GEOSCIENCES   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DEAKIN UNIVERSITY   (Australia)

^f UNIVERSITY OF EXETER   (United Kingdom)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN SULFIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; EXCITOTOXICITY; GENE EXPRESSION; MICROARRAY ANALYSIS; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION PROFILING; MICE; N-METHYLASPARTATE; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; RECEPTORS, N-METHYL-D-ASPARTATE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SULFIDES; TIME FACTORS;

EID: 79951788691     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22459     Document Type: Article

References (68)

1. Abe K, Kimura H. 1996. The possible role of hydrogen sulphide as an endogenous neuromodulator. J Neurosci 16: 1066-1071.
2. Arundine M, Tymianski M. 2004. Molecular mechanisms of glutamate-dependent neurodegeneration in ischaemia and traumatic brain injury. Cell Mol Life Sci 61: 657-668.
3. Bahr BA, Bendiske J. 2002. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83: 481-489.
4. Bannai S, Kitamura E. 1980. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 255: 2372-2376.
5. Baskar R, Li L, Moore PK. 2007. Hydrogen sulphide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J 21: 247-255.
6. Baskar R, Sparatore A, Del Soldato P, Moore PK. 2008. Effect of S-diclofenac, a novel hydrogen sulphide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 594: 1-8.
7. Beyer K, Lao JI, Carrato C, Rodriguez-Vila A, Latorre P, Mataro M, Llopis MA, Mate JL, Ariza A. 2004. Cystathionine beta synthase as a risk factor for Alzheimer disease. Curr Alzheimer Res 1: 127-133.
8. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC. 2003. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22: 8608-8618.
9. Cao Q, Zhang L, Yang G, Xu C, Wang R. 2010. Butyrate stimulated H(2)S production in colon cancer cell. Antioxid Redox Signal 12: 1101-1109.
10. Cheung NS, Beart PM, Pascoe CJ, John CA, Bernard O. 2000. Human Bcl-2 protects against AMPA receptor-mediated apoptosis. J Neurochem 74: 1613-1620.
11. Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM. 1998. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurons. Neuropharmacology 37: 1419-1429.
12. Cheung NS, Peng ZF, Chen MJ, Moore PK, Whiteman M. 2007. Hydrogen sulphide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacology 53: 505-514.
13. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455.
14. Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23: 4081-4091.
15. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lane HC, Rempicki RA. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4: P3.
16. Dombkowski RA, Russell MJ, Olson KR. 2004. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286: R678-R685.
17. Eghbal MA, Pennefather PS, O'Brien PJ. 2004. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 203: 69-76.
18. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo A-P, Currie RW. 2005. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia 21: 379-392.
19. Gaczynska M, Osmulski PA, Ward WF. 2001. Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev 122: 235-254.
20. Gadalla MM, Snyder SH. 2010. Hydrogen sulphide as a gasotransmitter. J Neurochem 113: 14-26.
21. Goodwin LR, Francom D, Dieken FP, Taylor JD, Warenycia MW, Reiffenstein RJ, Dowling G. 1989. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol 13: 105-109.
22. Hara M, Snyder S. 2007. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 47: 117-141.
23. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Dodd RL, Chan PH. 2005. Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons. J Cereb Blood Flow Metab 25: 41-53.
24. Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P. 2010. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimers Dis 20: S453-S473.
25. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS. 2010. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9: 135-146.
26. Hu LF, Lu M, Wu ZY, Wong PT, Bian JS. 2009. Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 75: 27-34.
27. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc 4: 44-57.
28. Hynd MR, Scott HL, Dodd PR. 2004. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45: 583-593.
29. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. 2009. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 11: 205-214.
30. Jimbo A, Fujita E, Kouroku Y, Ohnishi J, Inohara N, Kuida K, Sakamaki K, Yonehara S, Momoi T. 2003. ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res 283: 156-166.
31. Kimura H. 2000a. Hydrogen sulphide as a neuromodulator. Mol Neurobiol 26: 13-19.
32. Kimura H. 2000b. Hydrogen sulphide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 267: 129-133.
33. Kimura H. 2010. Hydrogen sulfide: from brain to gut. Antioxid Redox Signal 12: 1111-1123.
34. Kimura Y, Dargusch R, Schubert D, Kimura H. 2006. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 8: 661-670.
35. Kimura Y, Goto Y-I, Kimura H. 2010. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12: 1-13.
36. Kimura Y, Kimura H. 2004. Hydrogen sulphide protects neurons from oxidative stress. FASEB J 18: 1165-1167.
37. Mak SK, Kültz D. 2004. Gadd45 proteins induce G2/M arrest and modulate apoptosis in kidney cells exposed to hyperosmotic stress. J Biol Chem 279: 39075-39084.
38. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB. 2005. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci 1053: 356-375.
39. McCullough KD, Martindale JL, Klotz L-O, Aw T-K, Holbrook NJ. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Bio 21: 1249-1259.
40. Meriin AB, Sherman MY. 2005. Role of molecular chaperones in neurodegenerative disorders. Int J Hyperthermia 21: 403-419.
41. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT., 1989. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2: 1547-1558.
42. Nagai Y, Tsugane M, Oka J, Kimura H. 2004. Hydrogen sulphide induces calcium waves in astrocytes. FASEB J 18: 557-559.
43. Nakagawa T, Yuan J. 2000. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887-894.
44. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. 2006. Hydrogen sulphide is a mediator of cerebral ischemic damage. Stroke 37: 889-893.
45. Richardson CJ, Magee EA, Cummings JH. 2000. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 293: 115-125.
46. Rogers N, Paine S, Bedford L, Layfield R. 2010. Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration. Neuropathol Appl Neurobiol 36: 113-124.
47. Savage JC, Gould DH. 1990. Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography. J Chromatogr 526: 540-545.
48. Scheuer K, Maras A, Gattaz WF, Cairns N, Forstl H, Muller WC. 1996. Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7: 210-214.
49. Schröder M, Kaufman RJ. 2005. ER stress and the unfolded protein response. Mutat Res 569: 29-63.
50. Sherman MY, Goldberg AL. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29: 15-32.
51. Sherr CJ. 1995. D-type cyclins. Trends Biochem Sci 20: 187-190.
52. Silva D, Dikkes P, Barnes M, Lopez MF. 2009. Decreased motoneuron survival in Igf2 null mice after sciatic nerve transection. Neuroreport 20: 1414-1418.
53. Siman R, Noszek JC, Kegerise C. 1989. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9: 1579-1590.
54. Simpkins KL, Guttmann RP, Dong Y, Chen Z, Sokol S. 2003. Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci 23: 11322-11331.
55. Sullivan JM, Traynelis SF, Chen HS, Escobar W, Heinemann SF, Lipton SA. 1994. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13: 929-936.
56. Takahashi T, Katada S, Onodera O. 2010. Polyglutamine diseases: Where Does Toxicity Come From? What Is Toxicity? Where Are We Going? J Mol Cell Biol. 2: 180-191.
57. Tang G, Wu L, Wang R. 2010. Interaction of hydrogen sulphide with different ion channels. Clin Exp Pharmacol Physiol 37: 753-763.
58. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P. 2000. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249-258.
59. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA. 2002. GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 192: 327-338.
60. Warenycia MW, Goodwin LR, Benishin CG, Reiffenstein RJ, Francom DM, Taylor JD, Dieken FP. 1989. Acute hydrogen sulfide poisoning. Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol 38: 973-981.
61. Whiteman M, Armstrong JS, Chu SH, Siau J-L, Cheung NS, Halliwell B, Moore PK. 2004. The novel neuromodulator hydrogen sulphide: an endogenous peroxynitrite 'scavenger'? J Neurochem 90: 765-768.
62. Whiteman M, Cheung NS, Zhu Y-Z, Chu SH, Siau J-L, Wong BS, Armstrong JS, Moore PK. 2005. Hydrogen sulphide; a novel inhibitor of hypochlorous acid mediated oxidative damage in the brain? Biochem Biophys Res Commun 326: 794-798.
63. Whiteman M, Li L, Kostetski I, Chu SH, Siau J-L, Bhatia M, Moore PK. 2006. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343: 303-310.
64. Yamashima T, Kohda Y, Tsuchiya K, Ueno T, Yamashita J, Yoshioka T, Kominami E. 1998. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 10: 1723-1733.
65. Yin WL, He JQ, Hu B, Jiang ZS, Tang XQ. 2009. Hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. Life Sci 85: 269-275.
66. Zatz M, Starling A. 2005. Calpains and disease. N Engl J Med 352: 2413-2423.
67. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol 283: PH474-H480.
68. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D. 1998. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982-995.